Table 2.
Major clinical diagnoses in the Other Diseases groups of the sample of the ILULU-TB cohort that was selected for this study.
| HIV uninfected | HIV infected |
Total (% of OD group) |
|||
|---|---|---|---|---|---|
| Karonga | Cape Town | Karonga | Cape Town | ||
| Pneumonia/ Bronchitis/PCP |
12 (33%) | 6 (16%) | 15 (47%) | 15 (38%) | 48 (33%) |
| Malignancy or neoplasia other than KS* | 3 (8%) | 13 (35%) | 1 (3%) | 2 (5%) | 19 (13%) |
| Genitourinary | 6 (17%) | 4 (11%) | 2 (6%) | 1 (3%) | 13 (9%) |
| Meningitis (bacterial/viral/ unspecified) |
4 (11%) | 0 (0%) | 4 (13%) | 2 (5%) | 10 (7%) |
| Gastroenteritis/ Hepatitis |
0 (0%) | 2 (5%) | 0 (0%) | 6 (15%) | 8 (6%) |
| Kaposi's Sarcoma | 0 (0%) | 0 (0%) | 1 (3%) | 6 (15%) | 7 (5%) |
| Pyelonephritis | 0 (0%) | 7 (19%) | 0 (0%) | 0 (0%) | 7 (5%) |
| Cryptococcal meningitis | 0 (0%) | 0 (0%) | 2 (6%) | 3 (8%) | 5 (3%) |
| Pleural effusion/empyema (non-TB) | 0 (0%) | 1 (3%) | 0 (0%) | 4 (10%) | 5 (3%) |
| Bacteraemia (source not identified) | 1 (3%) | 0 (0%) | 4 (13%) | 0 (0%) | 5 (3%) |
| Other** | 5 (14%) | 0 (0%) | 0 (0%) | 0 (0%) | 5 (3%) |
| Hepatobiliary disease | 0 (0%) | 4 (11%) | 0 (0%) | 0 (0%) | 4 (3%) |
| Peritonitis | 3 (8%) | 0 (0%) | 1 (3%) | 0 (0%) | 4 (3%) |
| Malaria | 1 (3%) | 0 (0%) | 1 (3%) | 0 (0%) | 2 (1%) |
| IBD | 0 (0%) | 0 (0%) | 0 (0%) | 1 (3%) | 1 (1%) |
| Pyomyositis | 1 (3%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (1%) |
| Persistent generalised lymphadenopathy | 0 (0%) | 0 (0%) | 1 (3%) | 0 (0%) | 1 (1%) |
| TOTAL | 36 | 37 | 32 | 40 | 145 |
Data are stratified by HIV status and site.
*
Lung cancer (n = 7), lymphoma (n = 3), dermatological tumour (n = 2), unspecified (n = 2), mesothelioma (n = 1), hepatocellular carcinoma (n = 1), metastatic adenocarcinoma (n = 1), benign salivary gland tumour (n = 1).
**
Epilepsy (n = 3), headache (n = 1), pain unspecified (n = 1). One patient had no diagnosis listed, hence data is shown for 145 patients.